Concurrent injection of cold antibody allows PET imaging of orthotopic pancreatic tumor with "Cu -labeled anti -PD-L1

被引：0
|
作者：
Wen, Xiaoxia [3 ]
Zhao, Jun [3 ]
Wen, Xiaofei [1 ]
Shi, Sixiang [3 ]
Li, Tingting [2 ]
Li, Chun [3 ]
机构：
[1] Harbin Med Univ, Hosp 4, Harbin, Heilongjiang, Peoples R China
[2] Univ Elect Sci & Technol China, Chengdu, Sichuan, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
607
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Noninvasive PET imaging of tumor PD-L1 expression with 64 Cu-labeled Durvalumab
    Malih, Sara
    Lin, Wilson
    Tang, Zhongmin
    Deluca, Molly C.
    Engle, Jonathan W.
    Alirezapour, Behrouz
    Cai, Weibo
    Rasaee, Mohammad J.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 14 (01): : 31 - 40
  • [2] Imaging of PD-L1 modulation by gemcitabine using 89Zr labeled anti-PD-L1 antibody PET.
    Jung, Kyung-Ho
    Park, Jin Won
    Lee, Jin Hee
    Cho, Young Seok
    Lee, Kyung-Han
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 90 - 91
  • [3] PET imaging of PD-L1 using anti-PD-L1-B11 antibody in breast cancer tumor model
    Bansal, Aditya
    Barham, Whitney
    Liu, Xin
    Harrington, Susan
    Lucien-Matteoni, Fabrice
    Dong, Haidong
    Park, Sean
    Pandey, Mukesh
    DeGrado, Timothy
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [4] Preclinical antibody-PET imaging of PD-L1
    Brown, Emma L.
    Deweerd, Rachel A.
    Zidel, Abbey
    Pereira, Patricia M. R.
    FRONTIERS IN NUCLEAR MEDICINE, 2022, 2
  • [5] Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of 89Zr-Labeled Anti-PD-L1 Antibody Formats
    Bouleau, Alizee
    Nozach, Herve
    Dubois, Steven
    Kereselidze, Dimitri
    Chevaleyre, Celine
    Wang, Cheng-, I
    Evans, Michael J.
    Lebon, Vincent
    Maillere, Bernard
    Truillet, Charles
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (08) : 1259 - 1265
  • [6] PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a 177Lu-labeled αPD-L1 antibody
    Ren, Jingyun
    Xu, Mengxin
    Chen, Junyi
    Ding, Jie
    Wang, Peipei
    Huo, Li
    Li, Fang
    Liu, Zhibo
    THERANOSTICS, 2021, 11 (01): : 304 - 315
  • [7] PET Imaging of Tumor PD-L1 Expression with a 18F-labeled Bicyclic Peptide
    Wang, Xiaobo
    Liu, Zhiguo
    Yang, Weidong
    Kang, Fei
    Wang, Jing
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [8] 89Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
    Jung, Kyung-Ho
    Park, Jin Won
    Lee, Jin Hee
    Moon, Seung Hwan
    Cho, Young Seok
    Lee, Kyung-Han
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (05) : 656 - 664
  • [9] A 64Cu-labeled peptide-based PET radiotracers for imaging PD-L1 expression in preclinical tumor models
    Zhang, Siqi
    Hu, Kuan
    Zhang, Lulu
    Wang, Yanrong
    Wang, Xingkai
    Shen, Jieting
    Wang, Feng
    Zhang, Ming-Rong
    Wang, Rui
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [10] Synthesis and radiolabeling of diabody fragment of anti-PD-L1-B11 antibody for PET imaging of PD-L1 in a melanoma tumor mouse model
    Bansal, Aditya
    Lavoie, Roxane
    Lucien, Fabrice
    Kethamreddy, Manasa
    Dong, Haidong
    Park, Sean
    Pandey, Mukesh
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S193 - S194
12345